Using gene therapy to target aging

BioViva is working hard on gen therapies to target aging:

“We target cellular aging as it is the leading risk factor of most major pathology.”

Their CEO Lizz Parrish is the first one they treated using gen therapy. Here’s an interview:

2 Likes

Reminds me of this

1 Like

This is great, we need more old geezers that just won’t kick the bucket because public pension systems are too loaded with money and the sharing economy of abundance has been creating deflation!

Liz Parrish, the Founder and CEO of BioViva Sciences USA Inc, is best known for recently becoming the first person to be treated with gene therapy to reverse aging.

BioViva is committed to extending healthy lifespans using gene therapy. Liz is known as “the woman who wants to genetically engineer you.” She is a humanitarian, entrepreneur and innovator and a leading voice for genetic cures.

This talk, “Gene therapy to save the world”, was co-hosted by Oxford Transhumanism and Emerging Technologies (OxTET) and Oxford University Scientific Society. It was held at IEB building, Department of Engineering Science, Oxford, on Feb 23rd 2016.

Here’s a nice slide of the presentation